TCL Archive Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand March 26, 2010
TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research. October 22, 2004